Funds holding ASPIRE BIOPHARMA HOLDINGS INC
ISIN US7389203057 · United States · LEI 529900UC0AFER5IEH285
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 7.8K $
- Share of capital
- 0.1 % of 1.4M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 1,029 | 5.6K $ | 0.07 % | as of May 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 263 | 1.4K $ | 0.02 % | as of Jun 30, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 81 | 444.7 $ | 0.01 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 47 | 258 $ | 0.00 % | as of May 31, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1 | 5.3 $ | 0.00 % | as of Jun 30, 2026 ↗ |
Declared shareholders of ASPIRE BIOPHARMA HOLDINGS INC
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Lance Friedman | 7.92 % | 107,323 | as of Aug 4, 2026 · SCHEDULE 13G |
| GARY SHIRINYAN | 7.70 % | 99,900 | as of Jun 17, 2026 · SCHEDULE 13G |
| Rubenbauer Alois Ryan III | 5.00 % | 65,000 | as of Jun 25, 2026 · SCHEDULE 13G |
| Highbridge Capital Management, LLC | 0.00 % | 78 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ASPIRE BIOPHARMA HOLDINGS INC". https://titelia.com/en/stocks/aspire-biopharma-holdings-inc-US7389203057